Related Experiment Video
Updated: May 9, 2026
09:36
Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Halothane increases neuronal cell death vulnerability by downregulating miR-214 and upregulating Bax
1State Key Laboratory of Biomembrane and Membrane Biotechnology, College of Life Sciences, Peking University Beijing, 100871, China.
Summary
Halothane, an inhalational anesthetic, worsens neuron damage from amyloid-beta peptides. This occurs by reducing miR-214, increasing Bax protein, and raising Alzheimer
Area of Science:
- Neuroscience
- Anesthesiology
- Molecular Biology
Background:
- Inhalational anesthetics are common but may elevate Alzheimer's disease (AD) risk.
- Halothane is a frequently used inhalational anesthetic.
- Amyloid-beta (Aβ) peptides are implicated in AD pathogenesis and neuronal cell death.
Purpose of the Study:
- To investigate the cytotoxicity of halothane on primary rat neurons.
- To explore the role of halothane in mediating amyloid-beta-induced neurotoxicity.
- To elucidate the molecular mechanisms underlying halothane's effects on neuronal cells.
Main Methods:
- Primary rat neurons were cultured as a model system.
- Neurons were exposed to halothane and amyloid-beta (Aβ) under various conditions (with/without serum).
- Levels of miR-214 and Bax protein were quantified.
Main Results:
- Halothane enhanced Aβ-induced cytotoxicity in primary neurons.
- Halothane exposure led to the downregulation of miR-214.
- Downregulation of miR-214 correlated with increased Bax expression and subsequent cell death.
Conclusions:
- Halothane exacerbates amyloid-beta-induced neurotoxicity by downregulating miR-214 and upregulating Bax.
- This mechanism contributes to increased neuronal cell death.
- The findings suggest a potential link between inhalational anesthetics and Alzheimer's disease risk.
Related Concept Videos
01:20Inhalational Anesthetics: Overview
Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
01:16Cellular Injury IV: Necrosis
Necrosis is a form of irreversible cell death caused by severe injury such as ischemia, toxins, or trauma. Unlike programmed cell death, it is an uncontrolled, pathological process that typically provokes inflammation in surrounding tissues.Pathophysiologic ChangesNecrosis begins when cells sustain critical damage, leading to swelling of organelles, particularly mitochondria, and rapid ATP depletion. As energy levels decline, membrane ion pumps fail, leading to calcium influx and eventually,...
01:22Cellular Injury V: Apoptosis and Autophagy
Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
01:12Local Anesthetics: Adverse Effects
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...